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Under appropriate conditions fluorescent porphyrins 
and bilirubin present in blood and other body fluids can 
be examined spectrofluorometrically without prior ex-
traction. Uses of such direct fluorescence spectroscopy 
of porphyrins and bilirubin in studies and diagnoses of 
diseases associated with abnormal or impaired heme 
synthesis and metabolism are reviewed. The method of 
"front-face" fluorometry which allows quantitative as-
says of fluorescent porphyrins and bilirubin in small 
undiluted blood specimens is described. 
The cyclic tetrapyrroles, the porphyrins, have spectroscopic 
properties· distinctly different from those of their "linear" 
counterparts, e.g., the bile pigments biliverdin and bilil'ubin.t 
For example, the porphyrins exhibit absorption and fluOl'es-
cence spectra in the visible region of the spectrum characterized 
by relatively narrow bands, while bilirubin and biliverdin ex-
hibit broad, almost unstructured spectra. The visible electronic 
transitions of both the cyclic and " linear" tetrapyrroles are very 
strong (£",,,. > 10"). However, near room temperature, the fluo-
rescence yields of the porphyrins (metal free) are of the order 
of 0.1, while those of the "linear" tetrapyrroles are very much 
lower, <0.0001 for bilirubin in organic solvents. The extremely 
low yields for the "lineal''' tetrapyrroles are due to very efficient 
radiationless decay paths that return the molecules very rapidly 
(about 10 ps) directly to ground electronic states [1]. As a 
conseq uence, intersystem crossing (triplet state formation) is 
also of very low yield «0.01) in these compounds and they are 
generally not active as photodynamic agents (sensitizers of 
photooxidation) [2,3]. In contrast, the metal-free porphyrins 
have singlet state lifetimes of the order of 10 ns and exhibit 
high (>0.5) triplet state yields [4). Consequently, porphyrins 
are generally potent photodynamic agents [5]. 
It is well understood that the differences in the spectroscopic 
properties of cycl ic and linear tetrapyrroles are due to 2 conse-
quences of "breaking" the ring on going from the cyclic to the 
" linear" molecules. One resu lt is that the aromaticity or "circle 
of conjugation" of the porphyrin is lost when it is cleaved. This 
drastically changes energy levels in the molecules as well as the 
symmetry properties of the electronic states. Both large spectral 
shifts and differences in absorptivities are expected. 
The second consequence has to do with geometrical freedom. 
While conformational fl exibility in the porphyrins is confined 
chiefly to the side chain substituents, the linear tetrapyrroles 
are "floppy" molecules and some can adopt many different 
conformations. More importantly, freed from the geometrical 
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constraints of the ring structure, some excited linear tetrapyr_ 
roles can undergo rapid configmational (cis ~ trans, or E --'> Z) 
isomerization involving one or more of the carbon-carbon dou-
ble bonds in the remaining methine bridges [6,7]. This twisting 
mode may be much faster than both fluorescence and intersys_ 
tem crossing and is responsible for the low fluorescence yield 
and low triplet yield observed for bilirubin in fluid solution [ll 
While the differences in spectroscopic properties between 
cyclic and linear tetrapyrroles are immediately evident, it is a 
common characteristic that makes their fluorescent emissions 
useful in studies of and diagnoses of various diseases. Besides 
the presence of the 4 pyn-ole groups, the cyclic and "linem'" 
tetrapyrroles have at least one other common ch:uacteristic, 
namely, their spectroscopic properties are sensitive to the mi-
croenvironment. This sensitivity is expressed in different ways 
for the 2 classes of compounds. While different environments 
often lead to easily discernible spectral shifts in the porphyrins, 
the main effect observed in the linear tetrapyrroles are substan-
tial alterations of the fluorescence yields. This paper reviews 
the use of the fluorescence emissions from certain porphyrins 
in studies of primary and secondary protoporphyrinemias, and 
from bilirubin in studies of neonatal hyperbilirubinemia, and 
describes tluorometric diagnostic aids for these disorders as well 
as for other porphyria diseases. 
DIGRESSION: FLUOROMETRY OF WHOLE BLOOD 
SPECIMENS [8,9] 
Even in severe disease states, the most abundant tetrapynole 
in blood is, of course, heme (iron protoporphyrin), the prosthetic 
group of hemoglobin. The concentration of heme in blood of 
hematocrit 40 is about 8 mM. For comparison, the plasma 
concentration of bilirubin in neonatal jaundice rarely exceeds 
30 mg/dl [10], that is about 0.3 mM in blood, and the concen-
tration of "free" protoporphyrin in blood in protoporphyria is 
not known to exceed 2000 flg/ dl [11], or about 3 !lM. Conse-
quently one can be certain that for light of wavelengths in the 
region of the Soret band of heme (400-440 nm) the overwhelm-
ing fraction of the absorbed light is absorbed by heme groups. 
For example, less than about 0.1% of the absorbed blue light is 
absorbed by the "free" protoporph)'l'in in a specimen of blood 
from a patient with severe protoporphyria while more than 99~ 
is absorbed by heme. It is, therefore, not possible to assay for 
" free" protoporphyrin or for bilirubin in whole blood by ab-
sorption spectroscopy. Yet both bilirubin and protoporphyrin 
are easily assayed in whole blood by fluorometry [8,9]. This is 
possible because of the inherent sensitivity of fluorescence 
measurements and the important fact that heme does not 
fluoresc e (<I>r < 10- 1°). Thus, the fact that almost all the exci-
tation light is absorbed by heme does not matter because heme 
is "silent" in fluorescence. 
114 
As a consequence of the high absorbance of whole blood (A I 
cm is of the order of 1,000 near 415 nm) pract ically all excitation 
light in the blue is absorbed within the first 20 !lm or so of the 
sw1'ace of the specimen. This requires that the so-called "front-
face" geometry be employed for the fluorescence measure-
ments. In this mode the fluorescence emanating from the same 
"face" of the specimen that is irradiated is detected (Fig 1). For 
the case of a single fluorescent species that absorbs only a small 
fraction of the absorbed light, the fluorescence signal detected 
(Sr) is proportional to the ratio of the concentration of the 
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FIG 1. L eft : In the "righ t angle" geometry, commonly used in fluo-
rometry, the excitation light (Ex) impinges upon the sample cuvette in 
a direction 90° to that of the detected flu orescence emission, Right: In 
" front face" fluorometry the detector views light emi tted through the 
same surface of the specimen irradiated with excitation light. In the 
example depicted here the specimen is a drop of fluid (blood) on a 
horizontal glass cover slip al1(l the excitation light source and photo-
multiplier detector (PM) are placed below the specimen. This is the 
geometry used in the hematoflu orometer [8]. 
fluorescent species (cr) to t he concentration of hemoglobin 
(CHb).:j: 
Sf = constant X (eriCH") (1) 
Two important advantages obtain in using the "front-face" 
mode for fluorometry of whole blood. The first is that much 
more of the excitat ion ligh t is absorbed by the compound being 
assayed in the "fTont-face" optically dense mode compared with 
t he highly diluted "right-angle" mode. The consequence is that 
t he signal- to-noise ratio is higher and the sensit ivity is greater. 
The second advantage is that the volume of the blood specimen 
used need not be measured in the " front-face" mode. Ther e 
only needs to be sufficient specimen to aSSUl'e complete absorp-
tion of the excitation light, about 20 }lm pathlength for 430 nm 
excitation, and any excess does not matter. 
The principles of " front-face" flu orometry have been used as 
the basis of a fIlter fluorometer dedicated to fluorometry of 
small specimens of whole blood [8]. This instrument is called 
t he hematofluorometer . Besides the features of "front-face" 
fluorometry the instrument makes use of programmable digital 
e lectronics and calibrates itself as part of its automatic opera-
tion. 
FLUORESCENCE OF PROTOPORPHYRIN IN 
PRIMARY AND SECONDARY PORPHYRINEMIAS 
Both the wavelengths of the fluorescence spectral ba nds and 
t he quantum yield of fluorescence of porphine are affected by 
t he substituent groups on the periphery of the ring and by the 
chemistry at t he 4 pYlTole nitrogens as well as by t he molecular 
e nvironment. This section will be confined to a discussion of 
t he fluorescence properties of protoporphyrin IX, the porphyrin 
of heme, that is, the substituents around the porphyrin ring will 
be kept constant. The effects on the fluorescence proper t ies of 
ch anges in ring subsitutents will be mentioned later. Chemical 
differences at the 4 pyrrole nitrogens specifically refers to the 
number of protons bound (0 to 4), whether a metal ion is bound, 
:j: Equation (1) holds strictly for cases in which the distribution of 
the flu orescent species is the same as the distribution of hemoglobin in 
the specimen. This is the case, for example, for blood specimens in 
which the red cells contain protoporphyrin or zinc protoporphyrin. A 
slightly more complicated relation holds between the flu orescence 
signal strength and the concentration of flu orescent species when the 
distribution of the latte!' is not the same as that of the hemoglob in. 
Such a situation exists for bilirubin in whole blood where the fluorescent 
bilirubin resides in the plasma fraction and the hemoglobin is, of course, 
in the red ce LIs [1 2]. 
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a nd the kind of metal ion bound. S ince the discussion will be 
confined to aqueous systems neal' th e norma l pH of blood, it is 
expected that unless t here is a metal ion bound at the center of 
the po rphyrin there will probably be two protons bound, i.e. 
the neutral form of protoporphyrin obtains. 
Metal ion chelation affects protoporphyrin fluorescence dra-
matically [4]. Iron a nd other transition metal ions lead to severe 
quenching of the fluorescence [4]. It has a ll'eady been men-
tioned that heme, iron protoporphyrin, has a flu orescence yield 
that is proba bly smaller than 10- 10. Transition metal ions 
quench the porphyrin fluorescence by at least two mechanisms. 
Firstly, the heavy atom effect a nd/ or the unpa ired electrons in 
the ion can cause fast intersystem crossing (triplet state for-
ma tion) to occur. Secondly, many of t he transit ions metals ions 
have low lying electronic states that act as "sinks" for the 
excitation energy in the porphyrin ring precl uding emission 
from the porphyrin excited states. Only for a few metals do the 
porphyrin-metal complexes ex hibit flu orescences with quantum 
yields in excess of 0.01. These include the zinc and magnesium 
chelates. Neither zinc nor magnesium ions have electronic 
states that lie lower than the flu orescence state of the porphyrin 
ring, a nd neither increase the rate of intersystem crossing 
sufficiently to redu ce the fluorescence yield below 0.01. 
The work of Poh-Fi tzpatrick, P iomelli , Harber, Yamane and 
t his author on protoporphyrin fluorescence was prompted by 
the question of why people with severe lead intoxication ap-
peared no t to exhibi t t he cutaneous photosensit ivi ty common 
to those with congenita l protoporphyria [13,14]. It had been 
reported t hat the red cells of patients with severe lead in toxi-
cation can have concentrations of non heme pro toporphyrin 
even higher than levels fo und in the red cells of patients wi th 
protoporphyria. While other explanations for the diffe rence in 
photosensit ivity associated with the e 2 diseases had been 
suggested [15], we hypothesized that the biochemical basis for 
the difference had to do with the binding site of the protopor-
phyrin in the e rytlll'ocyte. 
The tradi t ional method for assaying erythrocyte protopor-
phyrin was to extract the spec imen wi th ethyl acetate/ acetic 
acid fo ll owed by extraction of the organic phase with hydl'O-
chloric acid [16]. This procedure, of course, removes t he pro-
toporphyrin from binding sites. Realizing that heme is not 
fluorescent, it became apparent to us t hat we could determine 
the fluorescence spectrum of the abnormally present porphyrin 
in the "sea" of heme by either greatly diluting specimens or by 
using " fron t face" methods. Spectral shifts that would reveal 
differences in the binding of the abnormally present protopor-
phyrin migh t be observed. 
Such a spectral differ ence is apparent in Fig 2 which shows 
the emissions from erythrocytes obtained from a n ad ul t male 
with congenital protoporphyria and a specimen from a child 
with lead intoxication. The characteristic porphyrin fluOl'es-
cence exhibits a 0-0 band maximum at 595 nm in the case of 
lead in toxication and at 626 nm in the case of protoporphyria. 
It was eventua lly discovered that the spectral shift is due to 2 
differ ences in the fluorescing species. The fluorescent porphyrin 
that accumulates in erythrocytes of patients with lead intoxi-
cation is, in fact, not metal free protoporphyrin but zinc proto-
porphyrin [17], while that associated with protoporphyria is the 
metal free pigment. Because acidic so lvents can r emove the 
zinc ion from the porphyrin, previous analyses of blood speci-
mens did not reveal zinc protoporphyrin in lead intoxication. 
The zinc protoporphyrin is und oubtedly bound to heme binding 
sites on globin [14]. Almost all of the metal free protoporphyrin 
found in erythrocytes of patients with protoporphyria is also 
bound to hemoglobin wi thin the cells. While the site of binding 
of the free protoporphyrin is a matter of controversy [18], we 
favor a site that is different fro m the heme site [14] (see F ig 3). 
Zinc protoporphyrin is potent ially as robust a photody namic 
agent as is protoporphyrin. Both compounds cross over to 
triplet states with high efficiency upon photoexcitatio n, and 
both can ensitize t he prod uction of singlet oxygen [AA Lamola, 
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FIG 2. Top: Fluorescence spectra recorded from specimens of eryth-
rocytes (suspended 1:800 in buffered saline) from a patient with pro-
toporphyria (EPP), a child with lead in toxication (PbI), and a normal 
adult volunteer. Specimens were excited with ligh t of a narrow wave-
length band centered near 400 nm. Bottom: Fluorescence spectra re-
corded from the same specimens after' adding a small amount of the 
detergent. dimethyldodecylamine oxide which lyses the cells and ex-
tracts the Iluorescent porphyrins (rom their binding sites. The detergent 
does not remove the zinc ion from zinc protoporphyrin. 
unpublished results]. It appeal'S that the lack of cuta neous 
photosensitivity associated with lead intoxication is du e to the 
. absence of sensit izing porphyrin in the skin of the patients. Zinc 
protoporphyrin is bound so t ightly to globin within the eryth-
rocytes th at it does not escape from the cells during their 
lifetime in circulation [13]. In contrast, it appears that th ere is 
a rapid diffusion of metal free porphyrin fyom th e circulating 
erythrocytes of patients with protoporphyria. Tra nsported by 
th e plasma, this porphyrin can enter cells in the skin [13,19]. 
This tra nsfer of erythrocyte porphyrin to skin can account for 
cu taneous photosensitivity even in the a bsence of a hepatic 
source of excess protoporphyrin [19]. Furthermore, the relative 
steady state concentrations of erythrocyte zinc protoporphyrin 
in lead intoxication and free erythrocyte protoporphyrin in 
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FIG 3. Schematic representations of the binding sites of the fluores_ 
cent porphyrins found in the erythrocytes of humans with lead intoxi-
cation, iron deficiency anemia, and erythropoietic protoporphyrin, and 
of mice rendered protoporphyric with griseofulvin. The boxes represent 
globin subuni ts, the bars represent protoporphyrin, the solid ci.rcles 
iron, and the open circles zinc. The zinc protoporphyrin replaces heme 
in a small fraction of the hemoglobin molecules. In the protoporphyrias 
the hemoglobin molecules contain the normal complement of heme 
and "extra" protoporphyrin binds at some other site(s) . 
protoporphyria do not reflect t he re lative amounts of these 
a bnormal porphyrins synthesized . The lifetime of zinc proto-
porphyrin in ci.rculating erythrocytes is about 100 times that of 
the free protoporphyrin. Thus the comparable steady state 
concentrations for the two abnormal porphyrins indicate a 
turnover of free protoporphy rin of the order of 100 times th at 
of the zinc protoporphyrin. 
It was subsequently shown that zinc protoporphyrin also 
accumulates in iron deficiency [17]. Rapid and inexpe nsive 
screening tests for lead intoxication and iron deficiency based 
upon the detection of zinc protoporphyrin in a drop of blood 
using a hematofluorometer h ave been developed and are in 
wide use in the USA [8,20). 
The absorption and fluorescence emission spectrum of m etal 
free protoporphyrin is sensitive to the micl"Oenvironment. The 
environment sensitive shifts observed have been utilized in 
several studies of protoporphyrias In ma n and animals 
[13,14,17,21-25)' 
A list of the wavelengths for the maxima of the major 
fluorescence bands, a nd the wavelengths of the maxima of the 
Soret ba nds in th e fluorescence excitation spectra of protopor -
phyrin in various solvents, bound to various proteins, and 
ch ela ted with zinc and magnesium is given in Table I. 
It is evident from the data of Table I that one can use 
fluorescence spectroscopy to differentiate among protopor -
phyrin molecules in different environments. For example, pro-
toporphyrin bound to hemoglobin emits fluorescence with a 
maximum at 626 nm while protoporphyrin in erythrocyte m em-
branes emits at 635 nm. This difference was used to gain 
information about the distribution of protoporphyrin in the 
erythrocytes of patien ts with protoporphyria. Suspensions of 
intact ery throcytes from these patients emit at 626 nm with n o 
indication of a minority species at 635 nm. This is not surprising 
since it can be shown that more than 99% of the extl'actable 
free erythrocyte protoporphyr ia is found in the cytosolic frac-
tion bound to hemoglobin [4). However, the question remained 
whether the small amount found in the pellet of stl"Oma is due 
to cytosolic protoporphyria entrained in the s troma fraction. 
Fluorescence from washed stroma prepared from patients with 
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TABLE I. Fluorescence maxima of protopofphyrin in different 
,nicroenuirorunents(l 
Solvent 
PBS" 
Ethanol 
DDAO" 
Microenvironment 
Complex (I :J) witll: 
Human serum albumin 
Bovine serum a lbumin 
R abbi t serum albumin 
Murine serum a lbumin 
Human hemopexin 
Rabbit hemopexin 
Human hemoglobin 
Murine hemoglobin 
Human globin 
Bound to: 
Human erythrocyte membrane 
Ch elated with: 
Zinc (in PBS) 
Magnesium (in PBS) 
" Data from references 17, 23, and 25. 
Emission max i- Exc itu lion max-
mum" (nm) imUJnr (nm) 
619 400 
632 403 
635 408 
635 408 
626 408 
633 408 
635 408 
629 408 
623 403 
625 g 
628 g 
625 403 
635 408 
584 
596 
b Maximum ± 1 nm of principa l (0-0) emission band. 
r Maximum ± 1 nm of major (Soret) band in excitation spectrum. 
d Phosphate buffered saline (0.15 M NaCI, 0.0] PO", pH 7.4). 
< 2% Dimethyldocylamine oxide in PBS. 
f In PBS. 
/! Not weU defined because of se lf-absorbance distortion. 
protoporphyria clearly show a maximum at 635 nm with li ttle 
evidence of a 626 peak. Thus one can conclude that there is a 
very small fraction (about 0.5%) of the erythrocyte protopor-
phyria that actually resides in the cell membrane. 
Because it is not always possible to obtain erythrocyte spec-
imens from patients with protoporphyria, a convenient substi-
t ute was devised called pseudo-pl'Otoporphyria erythrocytes 
w hereby erythrocytes from normal individuals are incubated 
with solutions of protoporphyrin [26,27]. The red cells quickly 
t ake up the porphyrin and exhibit the photosensitivity charac-
teristic of cells obtained from patients with protoporphyria . It 
was thought that these pseudo-proto porphyria cells were a 
more-or-less exact replica of erythrocytes obtained fl'Om pa-
tients. However, fluorescence spectroscopy clearly shows that 
t his conclusion is time dependent [Lamola AA, unpublished 
results]. While it is true that erythrocytes rapidly absorb pro-
toporphyrin from aqueous solution, the porphyrin remains in 
the cell membranes for times of the order of hoUl's. An aqueous 
s olution of protoporphyrin in buffered saline (pH 7.4) emits 
fluorescence with a maximum at 619 nm, and exhibi ts a rapid 
shift in emission wavelengths to 635 when erythrocytes a re 
a dded (Fig 4) . However, the 635 nm emission changes slowly, 
over the COUl'se of hours at 37°C to a 626 nm emission chru'ac-
teristic of protoporphyrin bound to hemoglobin. 
The difference between the fluorescence maximum of proto-
porphyrin in buffered saline (619 nm) and the maximum (635 
run) and much greater quantum yield of protoporphyrin bound 
to human serum albumin (Fig 5) was used to determine the 
afflnity constant for the albumin-protoporphyrin complex 
[25]. To determine the binding constant one must perform 
titrations of the 2 components in the concentration range com-
parable to the dissociation constant. The appropriate range for 
t he albumin-protoporphyrin complex is of the order of nano-
molal'. Fluorescence methods are among the few that provide 
the requisite sensitivity to be used for measurements in this 
concentration range. Some titration curves for the albumin-
protoporphyrin system ru'e shown in Fig 6. In the experiments 
solu tions of protoporphyrin at 1 and 3.3 nanomolal' were titrated 
with human serum albumin and the increase in fluorescence 
intensity at 635 nm was plotted as a fun ction of the albumin 
concentration. The data could be fitted very well using a n 
affinity constant of 3 x lOB M - 1 for a single binding site model. 
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solution of proroporphyrin in saline followed by washing. Wi thin 24 hI' 
at 37°C, the spectrum of the pseudo·EPP efythrocytes shi fts and 
appears the same as that from the EPP erythrocytes. 
Titrations at higher concentrations of the components revealed 
weaker secondary binding sites. These sites can be ignored in 
considerations of the distribution of protoporphyrin in the blood 
of pa tients with protoporphyria because t he protoporphyrin 
concentration is not known to approach the concentration of 
a lbumin. 
The relative affini t ies of hemoglobin and albumin for proto-
porphyrin were conveniently determined by fluorescence meth-
ods by simply recording spectra of solut ions of protoporphyrin 
conta ining various mixtures of the proteins (23]. If the COllCen-
tration of protoporphyrin is kept constant and the total protein 
is kept in excess and at a sufficiently high concentration to bind 
all the porphyrin, the fra ction of protoporphyrin bound to each 
of the proteins, determined directly from the spectra, gives the 
relative binding affini ties directly. In this way it was determined 
that the binding of protoporphyrin to hemoglobin is a bout 40 
times stronger than the binding of the porphyrin to albumin 
[23]. In a typical blood specimen the concentration of hemoglo-
bin is about 6 times that of albumin, so that at eq uilibrium it is 
expected that more than 99% of the porphyrin should reside in 
erythrocytes bound to hemoglobin, and less than 1% should 
reside in the plasma. This binding eq uilibrium in favor of 
hemoglobin nicely expla ined why protoporphyrin produced in 
the liver of a mouse by treatment with griseofulvin finds itself 
in the circulat ing erythrocytes (23]. 
Direct competition experiments using fluorescence spectros-
copy were also used to determine the relative affinities of 
albumin and human hemopexin for protoporphyrin (Fig 7). It 
was found that the affinity of albumin for protoporphyrin is 
four times that of hemopexin (25]. S ince albumin is present in 
plasma at a bout 50 to 100 times the concentration of hemopexin, 
it follows that most of the pOI'phyrin should be bound to 
albumin and less than 1% should be bound to albumin. This 
expectation is realized in the emission spectrum of protopor-
phyrin in plasma for which the maximum is 635 nm, identical 
to that of the albumin-protoporphyrin complex, with no evi-
dence for a contribution from a band at lower wavelengths 
corresponding to protoporphyrin bound to hemopexin (Fig 8). 
However, this r esult does not exclude hemopexin from a role in 
the clearance of protoporphyrin. The very high binding con-
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FIG 6. F luorescence titration curves. Solu tions of protoporphyrin in 
b uffe red (pH 7.4) saline were t itrated with human seru m a lbumin 
(HSA). Data points are the closed and opened c;i,.cles. T he curves are 
those calculated for single-site binding wi th an affinity of 3 x 10" M - '. 
stants for the complexes between protoporphyrin and albumin 
or hemopexin lead to an unbound protoporphyrin concentra-
t ion in plasma of about 0.001 nm! I t does not seem possible, 
t herefore, t hat the rapid clear ance of protqporphyrin by the 
fun ctioning liver could be based upon the uptake of unbound 
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FIG 7. Fluorescence spectra fr om mixtures of protoporphyrin (0.1 
11M) , human serum albumin (HSA) and human hemopexin (HHx). T h e 
HSA concentration was constant (0.2 11M) . Heference spectra with 
eit her H SA or HHX presen t alone are given in F ig 5. 
protoporphyrin . It may well be that a carrier is involved . 
Albumin is not known to enter the hepatocyte. H emopexin is 
known to carry hem e in to hepatocytes. T he approximately 5 
nM concentration of the hem opexin -protoporphyrin complex 
expected in the plasma of a "typical" patient wi th protoporphy-
ria could well accommodate the clearance rate assuming that 
hemopexin carries the porphyrin into the liver cells. 
DIFFERENTIAL DIAGNOSES OF PORP HYRIA 
DISEASES BY DIRECT FLUOROMETRY OF BODY 
FLUIDS 
The most common meth ods for assay of porphyrins in body 
fluids remain those based upon extraction of the porphYl"ins 
from the specimens followed by separation and assay of the 
diffe rent porphyrins present in the extract. As has been pointed 
out above, such procedUl-es lose information about the por-
phyrin binding sites of the porphyrins that may be usefu l in 
diagnosis. Assay of the porphyrins directly in the specim en 
(dilu ted or undilu ted as the situation requires) may preserve 
this information. Furthermore, compared wi th extraction meth-
ods, direct measurements on unextracted specimens may be 
simpler a nd more rapid . 
Poh-Fi tzpatrick and this author have poin ted out [21] that it 
is possible to go far in the diffe rent ial diagnosis of primary and · 
secondary porphyrinemias by examination of the flu orescence 
spectra of plasma and erythrocytes (see T able II) . The original 
report considered lead in toxication, iron deficiency anem ia, 
protoporphYTia, erythropoietic porphyria, and porphYl" ia cuta-
nea tarda [21]. Poh -Fitzpatrick has recently shown that t here 
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FIG 8. Fluorescence spectra of plasma samples diluted l :4 with 
b uffered saline. P lasma obtained from a norma l adul t with 0.3 /lM 
protoporphyrin added is compared wit h that from a patient with 
protoporphyria (EPP). Both spectra are iden tica l to t hat of protopor-
p hyrin bound to huma n serum a lbumin. 
is a plasma porphyrin fluorescence spectrum diagnostic for 
variegate porphyria [22]. The various porphyrins in val'ious 
m icroenvironments have fluorescence spectra with maxima at 
differ ent wavelengths. Protocols for direct quantitative flu oro-
metric assays of some of the porphyrin(s) present in blood have 
been developed [8]. It would not be difficu lt to develop such 
q ua ntitative fluorometric assays for the val'ious porphyrins that 
may occur in plasma, erythrocytes and urine. For example, it 
appeal's to be possible to determine total urinary porphyrin by 
direct fluorometry of Ul'ine specimens and to obtain a good 
estimate of the W'oporphyrin/coproporphyrin ratio [Lamola 
AA, Kochevar I, unpublished results]. I t is conceivable that a 
relatively inexpens ive microprocessor-controlled ("smart") 
fluorometer dedicated to different ia l quantitative assay of por-
phyrins in blood, plasma, and urine, i.e., a hematofluol'Ometer 
for complete analysis of porphyrins in body fluids, could be 
developed. 
RAPID FLUOROMETRIC ASSAYS OF BILIRUBIN AND 
BILIRUBIN BINDING IN WHOLE BLOOD 
Bilirubin, the product of heme catabolism in man, is a cyto-
toxin, in part because of its hydrophobicity and attendent 
propensity to bind to proteins and membra nes. Transported by 
serum albumin, t he pigment is taken up by hepatocytes a nd 
esterified to the diglucW'onide conjugate which both neutralizes 
its toxicity and prepares it for excretion by way of the bile. A 
common occurrence in the neonatal period is a temporary 
accumulat ion of unconjugated biljrubin du e to a delay in t he 
induction of conjugating activity in the liver. Jaundiced new-
borns must be followed carefully because of the possibili ty of 
bilirubin encephalopathy. Notwithstanding the large body of 
d ata indicating that individual infants tolerate . bilirubin to 
FLUORESCENCE METHODS 119 
different degrees [28], the management of jaundiced babies in 
most hospitals is based primarily upon the serum bilirubin 
concentration. It is widely held that this individual variation in 
risk for bilirubin encephalopathy is d ue to val'iation in the 
bilirubin binding capacity of the serum albumin [29]. Under 
norma l condi t ion this serum protein binds one bilu'ubin mol-
ecule with an affini ty (K" = 10; M - 1) at least 2 orders of 
magni tude larger than any other known binding site for bilu'u-
bin. Consequently albumin acts to sequester bilu·ubin. But 
when the bilirubin binding capacity of albumin approaches 
satW'ation, the concentration of bilirubin in t issue r ises dramat-
ically and the risk for bilu'ubin encephalopathy increases sub-
stantia lly. T hus there has been great in terest in the develop-
ment of assays for bilu'ubin binding capacity or other measures 
of bilirubin binding status in blood specimens [30]. While many 
such assays have been developed over the last decade, most al'e 
too complicated and inconvenient for routine use in the typical 
hospital laboratory. 
The influence of binding site upon the flu orescence yield of 
unconjugated bilil'ubin fo rmed the foundation for the develop-
ment of a series of fluorometric assays for bilirubin and bilu'ubin 
binding capacity in small specimens of whole blood [12,31]. 
TABLE II. Maxim.a of fluorescen ce spectra of pOlphy rin-containing 
blood fract.ions" 
Specimen 
E rythrocytes from patients with : 
E rythropoietic proto porphyria 
(EPP) (Protoporphyria) 
E rythropoietic porphyria 
Lead in tox ication 
Iron deficiency a nemia" 
Porphyria cu tanea tarda 
Variegate porphy ria 
Acute in termi ttent porphyria 
Heredita ry coproporphy ria 
P lasma from pa t ients with: 
E rythropoietic protoporphyria 
E rythropoietic porphyria 
Lead in tox ication 
Iron de ficiency anem ia 
Porphyria cutanea tarda 
Variegate porphyria 
Acute in termittent porphyria 
Heredi tary porphyria 
" Data from references 2 l a nd 22. 
Di luent 
PBS" 
PBS-DDAO" 
PBS 
PBS-DDAO 
PBS 
PBS-DDAO 
PBS 
PBS-DDAO 
PBS" 
625 
635 
620 
620 
595 
594 
595 
594 
635 
619 
619 
626 
6J9 
619 
397 
408 
393 
397 
425 
424 
425 
424 
408 
398 
398 
405 
398 
398 
" Maximum ± 1 nm of principal (0-0) ba nd. Spectr~ were recorded 
using a "red-sensit ive" photomu lt iplier (Hamamatsu H446 UH) . Ap-
paren t max ima will differ fo r detect.ors hav ing substantia lly different 
spectral responses. 
C Maximum ± I nm of t he major (Soret) excitation band recorded 
with the emission monochrometer set at emission ma ximum a nd cor-
rected for sloping background signa l. A I-cm cuvette was used. 
d Washed ce lls were suspended J:]ooo in phosphate buffered sa line 
(0 .15 M NaCL, 0.01 PO ... pH 7.4 ). Va lues for maxima in PBS hold only 
for s uspensions of in tact ce lls. 
" Washed ce lls dissolved (l:tOOO) in PBS con taining 2% dimethy l do-
decyla mine oxide (Ammonyx-LO, Onyx Chemical Company, J ersey 
City, NJ). 
,. In severe cases meta l free protoporphyrin (em iss ion max imum 626 
nm in PBS) in present a long with zinc protoporphyrin (emission max-
imum 595 nm) . 
" Erythrocytes exhibi t norma l small complement of zi nc protopor-
phyrin (emission maximum 595 nm) . 
" P lasma s pecimens d iluted I: to wi th phosphate buffered saline. A 1-
cm cuvette was used. 
, No porphyrin signa l detected except for severe cases in which metal 
free protoporphyrin is present in erythrocytes and gives rise t.o meta l 
free protoporphy rin in the plasma (emission maximum 635 nm) . 
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FIG 9. Relative flu orescence in tensity at 515 nm from a solu tion of 
human serum albumin (HSA) 3 g% in buffered saline as a function of 
added bilirubin in the absence (0 ) and presence (\7) of 3% dimethyl-
dodecylamine oxide detergent. In t he absence of detergen t only that 
bilirubin bound to t he primary binding site on HSA is detected by 
iluorescence. When the detergent is added all t he bilu'ubin becomes 
incorporated into detergen t micelles and is rendered fluorescent so t hat 
aU the bilirubin is assayed. The maximum flu orescence signal obtained 
in t he absence of detergent is proportional to the bilirubin binding 
capacity of the a lbumin solution. Virtually identical curves are ob tained 
when whole blood specimens are titrated with bilirubin. 
These assays, which can be run on a hematofluorometel', are 
simple and rapid. 
The fluorometric assays ar e based upon studies of the fluo-
rescence properties of bilirubin in various blood fractions. While 
bilirubin bound to the most affinitive site on albumin exhibits 
fluorescence with a low quantum yield (0.0016 at 22°C), un-
bound bilirubin , e.g., bilirubin dissolved in aqueous buffer, has 
a yield that is less than 1/50th as large. 
When a solution of albumin is titrated with bilirubin, the 
flu orescence intensity increases linearly with added bilil'ubin 
until the bilirubin concentration approaches that ofthe albumin 
when a plateau is reached in fluorescence intensity. Othel' 
methods of measuring bilirubin binding to a lbumin indicate the 
protein can bind mOl'e than one bilirubin molecule. However, 
bilirubin bound to these weaker sites is not obsel'vably fluores-
cent nor does it perturb the fluorescence of the bilu'ubin bound 
at the most affinitive site. Thus the f1uorescence signal from a 
mixture of bilil'Ubin and albumin reflects the quantity of bili-
rubin bound at the primary binding site of the pl'Otein . 
Because of its hydJ'ophobicity, bilirubin binds to many Pl'O-
teins found in plasma albeit with affinities much lower than 
that for the primary site of albumin. However, bilil'ubin bound 
to most other plasma pl'Oteins fluoresces with insignificant 
yields. El'ythrocytes have a large capacity fol' binding bilirubin. 
The pigment binds both to the membrane of the red cell as 
well as to hemoglobin in the cytosol. When bound to the 
membrane, bilirubin shows only a very weak fluorescence com-
pared to that bound to albumin. Bilirubin bound to hemoglobin 
is not fluorescent. Taken together, these observations indicate 
t hat to a good approximation only that bilirubin bound to the 
pl'imal'Y site of albumin is fluorescen t in blood. This is bome 
out by t he fluorescence t itration curve for whole blood mea-
sw'ed by means of "front-face" fluol'ometry using the hemato-
fluorometer. The curve is very similar to that obtained for a 
solution of albumin of the same concentration as found in the 
blood specimen (Fig 9) . 
Assays for albumin-bound bilirubin and bilirubin binding 
capacity have been developed based upon th e obsel'vations 
described above. Once calibrated and pl'ogrammed to make 
corrections for th e hematocrit dependence of the fluorescence 
intensity, the hematofluorometer can be used to determine the 
albumin-bound bilimbin level directly from the fluorescence 
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signal obtained from a drop of unprocessed blood. The total 
bilirubin binding capacity (concentl'ation of functional primru-y 
albumin binding sites for bili.rubin) can be obtained from the 
f1uor escence signal from a drop of blood to which bilirubin is 
added (as the sodium salt for rapid dissolu t ion) in sufficient 
quantity to saturate t he albumin binding. The incremental 
fluorescence signal obtained upon addition of t he bilu-ubin 
reflects the reserve binding capacity. 
FluOl'escence from bilu'ubin dissolved in micelles of a variety 
of detergents is of comparable magnitude to that from albumin-
bound bilu'ubin. One of these detergents, dimethyldodecylam-
ine oxide, DDAO, can effectively and rapidly extract bilil'Ubin 
from all blood binding sites. Within a few minutes after addition 
of DDAO (3%), virtually all the bilirubin in the lysed blood 
specimen is sequestered in detergent micelles (Fig 9). Thus, the 
total blood bilirubin concentration can be determined from the 
intens ity of fluol'escence of a specimen to which detergent was 
added. This concentration, of course, includes t hat bilil'ubin 
which had been found in red cells and ordinarily not accounted 
fol' in the tl'aditional serum bilirubin determinations. 
In practice all 3 measurements, a lbumin-bound bilu'ubin, 
total blood bilirubin, and the resel've binding capacity, can be 
run on less than 0.2 ml of whole blood within 15 min from 
obtaining the specimen. 
In addition to the reserve binding capacity, the hematofluo-
rometer assays provide other ways to moni tor bilil'ubin binding 
status. For example, it has been shown that B/ R, the ratio of 
albumin-bound bilil'ubin to reserve capacity as determined by 
the hematofluorometer, is precisely proportional to the un-
bound bilirubin concentration (measured by the "pel'Oxidase" 
m ethod) as predicted by the mass action law (Lamola AA, 
Wells R, Hammond K, Blumberg WE, unpublished results). 
Another view of binding status is provided by the parameter 
(T -B)/T which represents the fraction of bilirubin not not 
bound to albumin and which reflects deficiency in bilirubin 
binding. Values of (T - B) / T determined with the hematofluo -
rome tel' conelate well with other measures of bilil'ubin binding 
and with clinical factors associated with gestational maturity 
[32) [McClead R, Fanaroff A, Blumberg WE, Lamola AA, 
unpublished results]. 
REFERENCES 
1. Greene BI, Lamola AA, S hank CV: Picosecond prima ry photopro -
cesses of bilirubin bound to human serum albumin. Proc Natl 
Acad Sci USA, to be published April 1981 
2. Matheson IBC, Curry NU, L ee J: The photochemical quantum 
yield for t he self-sensit ized photoox idation of bilirubin. Photo-
chem Photobiol 31: 115-120, 1980 
3. Lightner DA: The photoreactivity of bilirubin and related pyrroles. 
Photochem Photobiol 26:427-436, 1977 
4. La mola AA: Funda mental aspects of the spectroscopy and photo-
chemistry of organic compounds; electronic energy transfer in 
biologic systems and photosensit ization, Sunlight and M a n. Ed-
ited by MA Pathak, LC Harbel', M Seiji, A Kukita. T okyo, Univ. 
T okyo Press, 1974, pp 47-52 
5. Spikes JD: A review of porphyrins as photosensitizers. Ann New 
York Acad Sci 244:496-508,1975 
6. Falk H, N eufingerl F: On the chemistry ofpyrro le p igments, XXVI: 
The anaerobic photochemistry of bile pigments: The lumines-
cence of bile pigment partial stl'uctures and in tegral pigments. 
M onatschfte Chemie 110:987-1001, 1979 
7. M cDonagh AF, Light ner DA, Woold.ridge TA: Geometric isomeri-
zation of bilirubin-IXo: and its dimethyl ester. J CS Chem Comm: 
110-ll2, 1979 
8. Blumberg WE, Eisinger J , Lamola AA, Zuckerman D: Zinc proto-
porphyrin level in blood determined by a portable hematoflu o-
rometer: A screening device for lead poisoning. J Lab Clin M ed 
89:712-721, 1977 
9 . E isinger J , Flores J : Front,face fluorometry of liquid samples. Anal 
Biochem 94:15- 21, 1979 
10. Schmid R, McDonagh AF: Hyperbilirubinemia, The Metabo lic . 
Basis of Inherited Disease. Edited by JB Stanbury, JB Wyn-
gaarden, DS Fredl'ickson. N ew York, M cGraw-Hill, 1978, pp 
1121-1159 
11. D eLeo V A, Poh-Fitzpatrick ME, Math ews-Roth M, H arber L C: 
Erythropoietic proto porphyria. 10 years' experience. Am J M ed 
60:8- 22, 1966 
July 1981 
12. Lamola AA, Eis inger J, B lu mberg WE, et al: Fluorometric study of 
t he partition of bilirubin among blood components: Basis for 
rapid microassays of bilirubin and bilirub in binding capacity in 
whole blood . Anal Biochem 100:25-27, 1980 
13. Piomelli S, Lamola AA, Poh-Fitzpatrick MB, Harber LC: Eryth-
ropoietic protoporphyria a nd Pb intoxication: The molecular 
basis for d ifference in cutaneous photosensitivity. 1. Different 
rates of diffusion of protoporphyrin from the eryth rocytes, both 
in vivo and in vitro. J Clin Invest 56: 1519-1527, 1975 
14. Lamola AA, Piomelli S, Poh-Fitzpatrick MB, Yamane T, Harber 
LC: Erythropoietic protoporphyria and Pb In tox ication: The 
m olecular basis for difference in cutaneous photosensitivity II. 
Different binding of eryth rocyte protoporphy rin to hemoglobin. 
J Clin Invest 56:1528-1539, 1975 
15. Scholnick P , Mru'ver HS, Schmid R: Erythropoietic protoporphy ria: 
Evidence for mul tiple sites of excess protoporphyrin formation. 
J Clin Invest 50:203-207, 1971 
16. Schwru·tz S, Berg MH, Bossenmaier I, et al: Determinations of 
porphyrins in bio logical materials, Methods of Biochemical Anal-
ysis. Edited by D Glick. New York, Interscience, vol 8, 1960, pp 
253-270 
17. La mola AA, Ya mane T: Zinc protoporphyrin in the erythrocytes of 
patients with lead in toxication and iron deficiency anemia . Sci-
ence 186:936-938, 1974 
18. van Steveninck J , Dubbleman TMAR, de Goeij AFPM, Went LN: 
Binding of p rotoporphy rin to hemoglobin in red cells of patients 
wit h erythropoietic proto porphyria. H emoglobin 1:679-690, 1977 
19. Lamon JM , Poh-F itzpatrick MB, Lamola AA: Hepatic protopor-
phyrin production in human protoporphyria. Effects of intra ve-
nous hematin a nd analysis of erythrocyte protoporphyrin d istri-
bution. Gastroenterology 79:115-1 25, 1980 
20. Erythrocyte protoporphyrin proficiency testing, Ju ly 1980. U.S. 
D ept. Healt h and Human Services, Public Healt h Service, Center 
fo r D isease Control, August, 1980 
21. Poh-Fitzpatrick MB, Lamola AA: Direct spectrofluorometry of 
diluted erythrocytes a nd p lasma: A rapid diagnostic method in 
primary and seconda ry porphyrinemias. J Lab Clin Med 87:362-
FLUORESCENCE METHODS 121 
370, 1976 
22. Poh-Fi tzpatrick MB: A plasma porphy rin fluorescence mru'ker for 
variegate porphyria. Arch Dermato l 116:543-547, 1980 
23. Poh-Fitzpatrick MB, Lamola AA: Compru'ative study of erythro-
poietic protoporphyria a nd griseofulvin-induced murine proto-
porphyria. Binding affi ni ties, distribution , and fluorescence spec-
tra in various blood fractions. J C lin Invest 60:380-389, 1977 
24. Roscoe DE, N ielsen SW, Lamola AA, Zuckerman DM: A simple, 
quan t itative test for erythrocytic protoporphyrin in lead-poi-
soned ducks. J Wi ldlife Dis 15:127- 135, 1979 
25. Lamola AA, Asher T, Muller-Eberhru'd U, Poh-Fitzpatrick ME: 
Hemopexin, a lbumin a nd t he clearance of plasma protopor-
phyrin. Biochem J , in press 
26. Goldstein BD, Harber LC: E rythropoietic protoporphyria: Lipid 
peroxidation and red cell membrane damage associated with 
photohemolysis. J Clin Invest 51:892-902, 1972 
27. Schothorst AA, Van St.eveninck J , Went LN, S uurmond D: Proto-
porphyrin-induced photohemolysis in protoporphyria a nd in nor-
mal red cells. Clin Chim Acta 28:41-49, 1970 
28. Gartner LM, Snyder RN, Chabon RS, et a!.: Kern icterus: high 
incidence in premature infa nts wit.h low serum bilirubin concen-
t rations . Pediatrics 45:906- 913, 1970 
29. Wennberg RP, Ah lfo rs CE, Rasmussen LF: The pathochemistry of 
kernicterus. Eru'ly Human Development 3/ 4:353-365, 1979 
30. Lee KS, Gar tne r LM: Bilirubin binding by plasma proteins: A 
cri tica l evaluation of methods and cl inica l implications, Reviews 
ill. Perinatal Medicine. Edited by EM Scarpelli , EV Cosmi. New 
York, Raven Press, vol 2, 1978, pp 319- 343 
31. Brown AK, E isinger J, Blumberg WE, et a1.: A rapid fluorometric 
method for determining b iliru bin levels and binding in the blood 
of neonates: Comparisons wit h a diazo method a nd with 2-(4'-
hydJ'oxybenzene)azobenzoic ac id dye binding. Pediatr ics 65:767-
776, 1980 
32. Cashore WJ, Oh W, Blumberg WE, Eisinger J , La mola AA: Ra pid 
fl uorometric assay of bilirubin a nd b ilirubin binding capacity in 
blood of jaundiced neonates: comparisons with other methods. 
Pediatrics 66:4ll -4 16, 1980 
